What is the purpose of this test?
The Morgan Prenatal Blood Test Panel #2 is designed to check important health factors for pregnant women. It includes a Hepatitis B Surface Antigen test to screen for hepatitis B, which can be passed to the baby during childbirth if not managed. The panel also includes ABO Grouping and RH Typing, which determine the mother’s blood type and Rh factor. Knowing these details is crucial because if the mother has a negative Rh factor and the baby has a positive one, it can lead to complications without proper treatment.
This panel also includes an HIV-1/2 Preliminary Blood Test (4th generation) to detect HIV, which is important for preventing transmission to the baby. Additionally, it screens for syphilis using the RPR (Rapid Plasma Reagin) test and checks for immunity to rubella through the Rubella Antibodies IgG test. These tests help identify potential health issues that could affect both the mother and baby, ensuring that any necessary precautions can be taken early in the pregnancy.
The Morgan Prenatal Blood Test Panel #2 includes the following:
- Hepatitis B Surface Antigen - is a blood test that detects the presence of the hepatitis B virus in the body. Its significance to prenatal health lies in identifying whether a pregnant woman is infected with hepatitis B, which can be transmitted to the baby during childbirth. Early detection allows healthcare providers to implement preventive measures, such as vaccination for the newborn and antiviral treatments for the mother, to reduce the risk of transmission and ensure the health of both mother and child.
- Rubella Antibodies IgG - is a blood test that measures the presence of IgG antibodies against the rubella virus, indicating whether a person has been vaccinated or previously infected. Its significance to prenatal health lies in assessing a pregnant woman's immunity to rubella, which can cause serious birth defects if contracted during pregnancy. Knowing a woman’s rubella immunity status helps healthcare providers take necessary precautions to protect the fetus and ensure a healthy pregnancy.
- RPR - is a blood test used to screen for syphilis, a sexually transmitted infection. Its significance to prenatal health lies in detecting syphilis early in pregnancy, as untreated syphilis can lead to serious complications for both the mother and the baby, including miscarriage, stillbirth, or congenital syphilis. Early diagnosis and treatment of syphilis during pregnancy help ensure a healthier outcome for both the mother and the newborn.
- HIV 1 and 2 Preliminary Blood Test (4th generation) - is a blood test that detects both HIV antibodies and the p24 antigen, providing early identification of HIV infection. Its significance to prenatal health lies in screening pregnant women for HIV, as early detection allows for timely intervention and treatment to reduce the risk of mother-to-child transmission during pregnancy and childbirth. Proper management of HIV can significantly improve health outcomes for both the mother and the baby, ensuring a healthier pregnancy.
- ABO Group and RHO(D) Typing - are blood tests that determine an individual's blood type (A, B, AB, or O) and the presence of the Rh factor (positive or negative). Their significance to prenatal health lies in ensuring compatibility between the mother and fetus; incompatible blood types can lead to complications during pregnancy, such as hemolytic disease of the newborn. Knowing these blood types helps healthcare providers manage pregnancies more effectively and prevent potential risks to both the mother and baby.
Benefits of the Morgan Prenatal Blood Test Panel #2:
- Hepatitis B Screening: Detects Hepatitis B infection for maternal and fetal protection.
- ABO Grouping: Determines blood type for safe transfusion if needed.
- RH Typing: Identifies Rh factor to prevent complications in pregnancy.
- HIV Screening: Tests for HIV-1/2 to ensure early intervention if necessary.
- Syphilis Detection: Includes RPR test to screen for syphilis, protecting maternal and fetal health.
- Rubella Immunity: Assesses immunity to rubella to reduce infection risks.
- Comprehensive Assessment: Provides a thorough evaluation of key prenatal health markers.
- Informed Care Decisions: Aids healthcare providers in making informed prenatal care choices.
- Early Detection: Facilitates timely identification of potential health issues.
- Convenient Testing: Easy access to essential prenatal tests through Walk-In Lab.
Preparation:
Patient should maintain a stable diet for 2–3 weeks before blood collection and fast for 12–14 hours prior. Stop biotin 72 hours before collection.
Test Results:
2-3 days. May take longer based on weather, holiday, or lab delays.
